openPR Logo
Press release

Revolutionary Breakthrough for Schizophrenia; Bleuler by 52Platform Receives Funding

01-22-2025 05:58 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: Notorial
Revolutionary Breakthrough for Schizophrenia; Bleuler

Image: https://www.globalnewslines.com/uploads/2025/01/1737537886.jpg

Bleuler seeks to redefine clinical management with advanced artificial intelligence and personalized solutions.

The project aims to improve patients' quality of life and optimize healthcare system costs.

52Platform [https://www.52platform.com/], a leader in neuroscientific innovation, has announced Bleuler, a revolutionary project aimed at developing a platform to transform the treatment of schizophrenia. Designed with the most advanced capabilities of artificial intelligence, Bleuler aspires to provide personalized solutions based on accurate data. This international project collaborates with Synaptia Health Group in Spain, MJN Neuro, the National Institute of Neurology and Neurosurgery "Manuel Velasco Suarez" in Mexico, Rey Juan Carlos University, and the investment fund Robby & Co. [https://www.robbyandco.com/]

Schizophrenia affects more than 25 million people worldwide. This disorder poses significant challenges due to variability in patient responses to current treatments. Bleuler, still in the study phase, focuses on developing an innovative clinical approach that combines electroencephalographic biomarkers and advanced cognitive assessments through artificial intelligence.

"Bleuler has the potential to revolutionize schizophrenia healthcare," said Adrian Trejo de la Rosa, CEO and co-founder of 52Platform. "This project is a step toward more precise treatment, which will improve patients' quality of life and give physicians reliable technological tools for making critical decisions. Our vision does not stop here; we want to expand this model to other neurological disorders and continue leading the future of personalized medicine."

The development of Bleuler will be possible thanks to a grant of 973,811.33 from a total budget of 1,604,067, awarded by the Centre for Technological Development and Innovation (CDTI, E.P.E.), a Public Business Entity under the Ministry of Science, Innovation and Universities. This funding, under its program supporting high-impact R&D projects, will allow for advancements in research, validation of the technology, and refinement of the platform design.

Technological innovation at the service of patients

Bleuler aims to detect clinical changes in patients early and adjust treatments according to their individual needs. Current studies include the development of wearable devices capable of monitoring brain activity from home, combined with automated cognitive analysis systems. These tools are designed to improve the quality of care and reduce unnecessary hospitalizations.

The project is expected to be ready for implementation by November 2026. This goal reinforces the commitment of collaborators to provide a solution that optimizes schizophrenia treatment in both public and private institutions. In addition to the clinical impact, Bleuler aims to improve the sustainability of the healthcare system in the long term by reducing costs associated with prolonged treatments. Although the platform is still under development, the projected advancements promise to significantly benefit patients and healthcare systems.

"Bleuler marks the beginning of a new era in personalized medicine," concluded Trejo de la Rosa. "We are committed to developing innovative solutions that not only transform the treatment of schizophrenia but also set new standards for other complex disorders."

About Robby & Co

Based in Palo Alto, California, Robby & Co is an innovative Venture Capital firm focused on supporting and empowering neurodivergent talent, with the team's own experiences serving as the starting point, as the majority of its members are neurodivergent.
Media Contact
Company Name: Robby & Co LLC
Contact Person: Press Office
Email: Send Email [http://www.universalpressrelease.com/?pr=revolutionary-breakthrough-for-schizophrenia-bleuler-by-52platform-receives-funding]
Country: United States
Website: https://www.52platform.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Revolutionary Breakthrough for Schizophrenia; Bleuler by 52Platform Receives Funding here

News-ID: 3828351 • Views:

More Releases from Getnews

Pelican ADU Builders Expands Services to Meet Growing Demand for Accessory Dwelling Units in Irvine
Pelican ADU Builders Expands Services to Meet Growing Demand for Accessory Dwell …
Image: https://www.globalnewslines.com/uploads/2025/09/1759243297.jpg Pelican ADU Builders, a leading name in residential construction and design, has announced an expanded focus on providing innovative housing solutions for families and property owners in Southern California. With the increasing popularity of Accessory Dwelling Units (ADUs), the company continues to deliver high-quality designs that maximize space, functionality, and long-term value. As California addresses housing shortages and evolving family needs, more residents are searching for trusted ADU builders near
Core Flooring Center Expands Product Lines and Design Support for Winter Park Homes
Core Flooring Center Expands Product Lines and Design Support for Winter Park Ho …
Image: https://www.globalnewslines.com/uploads/2025/09/1759238222.jpg Core Flooring Center has updated its showroom offerings and installation scheduling to better match homeowner expectations for durable, stylish floors. The team has refined consultation processes and added demonstration areas that help homeowners imagine how different materials perform in light, traffic, and seasonal humidity. Staff members focus on providing clear explanations and practical timelines, ensuring projects move forward with minimal disruption. Durable, modern plank options for daily life There has been
Landmark Exteriors Delivers Comprehensive Home Improvement for Halloween in Livermore CA
Landmark Exteriors Delivers Comprehensive Home Improvement for Halloween in Live …
Image: https://www.globalnewslines.com/uploads/2025/09/1759244835.jpg Landmark Exteriors readies homes in Livermore for the Halloween season with changes that refresh both inside and out. Livermore, CA - September 30, 2025 - Landmark Exteriors prepares its services for the Halloween season to improve the curb appeal and comfort for homes across Livermore. The company coordinates one-point project leadership, clear pricing, and fast scheduling. Local families can prep porches and living rooms before guests arrive on October nights. Image:
Tom Needham Insurance Offers ATV Insurance Solutions for Off-Road Enthusiasts
Tom Needham Insurance Offers ATV Insurance Solutions for Off-Road Enthusiasts
Image: https://www.globalnewslines.com/uploads/2025/09/1759244413.jpg Tom Needham Insurance highlights new ATV coverage, giving North Carolina riders flexible protection options for off-road adventures and beyond. Greensboro, NC - September 30, 2025 - Tom Needham Insurance announces a focused ATV insurance program for riders across North Carolina. The agency presents clear options for liability, comprehensive, collision, medical payments, gear, and trailer coverage. Clients receive guidance that fits trail rides, farm use, and weekend trips to public lands. Image:

All 5 Releases


More Releases for Bleuler

52Platform Introduces Bleuler: A Revolutionary Advance in Schizophrenia Treatmen …
Image: https://www.globalnewslines.com/uploads/2025/01/1737641669.jpg Barcelona - January 24, 2025 - 52Platform [https://www.52platform.com/], a leader in neuroscientific innovation, has announced Bleuler, a groundbreaking project to develop a platform designed to transform the treatment of schizophrenia. Engineered with the most advanced capabilities of artificial intelligence, Bleuler aims to provide personalized solutions based on precise data. This international project involves collaboration with Synaptia Health Group [https://synaptia.es/] in Spain, MJN Neuro, the National Institute of Neurology and